Cases 61 - 70 of 1,460
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al
as 1:2023cv00964
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Bionpharma Inc.
as 1:2023mc00396
Plaintiff:
Azurity Pharmaceuticals, Inc.
Defendant:
Bionpharma Inc.
Petitioner:
QHP Capital GP, LLP
Floyd v. Zynerba Pharmaceuticals, Inc. et al
as 1:2023cv00958
Plaintiff:
Michael Floyd
Defendant:
Zynerba Pharmaceuticals, Inc., Armando Anido, Warren D. Cooper and others
Smith v. Zynerba Pharmaceuticals, Inc. et al
as 1:2023cv00947
Plaintiff:
Morgan Smith
Defendant:
Zynerba Pharmaceuticals, Inc., Armando Anido, Warren D. Cooper and others
Stone v. Reata Pharmaceuticals, Inc. et al
as 1:2023cv00940
Plaintiff:
Philip Stone
Defendant:
Reata Pharmaceuticals, Inc., J. Warren Huff, Christy J. Oliger and others
Par Pharmaceutical, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00866
Plaintiff:
Par Pharmaceutical, Inc. and Epic Par Innovation Company, LLC
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Ajanta Pharma Limited
as 1:2023cv00847
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Ajanta Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Ajanta Pharma Limited
as 1:2023cv00849
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Ajanta Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Boehringer Ingelheim Corporation et al
as 1:2023cv00848
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Ajanta Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
